FDA Adverse Event Death Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 17503660 · Received August 10, 2023

Report

Report Number
3004464228-2023-20441
Event Type
Death
Date Received
August 10, 2023
Date of Event
July 11, 2023
Report Date
July 25, 2023
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120002
PMA / PMN Number
K122953
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION, DIABETIC KETOACIDOSIS AND DEATH. NO LOT RELEASE RECORDS WERE REVIEWED, AS THE PRODUCT LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT HAD DIED WHILE IN THE HOSPITAL WITH DIABETIC KETOACIDOSIS (DKA). THE PATIENTS POD WAS REMOVED ONCE THEY GOT TO THE HOSPITAL. THE PATIENT WAS DIAGNOSED WITH DKA AND PNEUMONIA. THE PATIENT HAD BEEN IN THE INTENSIVE CARE UNIT (ICU) FOR 4 DAYS AND THEN WAS TRANSFERRED TO THE ONCOLOGY DEPARTMENT. THE PATIENT HAD PASSED AWAY ON THE 11TH DAY IN THE HOSPITAL. NO FURTHER INFORMATION WAS PROVIDED AS TO THIS EVENT. IT SHOULD BE NOTED THE PATIENT SUFFERED FROM STAGE 4 CANCER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
851478 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 14000 20385081120002

Patients

Seq Age Sex Outcome Treatment
1 72 YR Male Death